125 related articles for article (PubMed ID: 33491994)
1. Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.
Duque P; Chasco-Ganuza M; Burgos-Santamaria A; Terradillos E
Blood Coagul Fibrinolysis; 2021 Jun; 32(4):298-301. PubMed ID: 33491994
[TBL] [Abstract][Full Text] [Related]
2. Impaired fibrinolysis in critically ill COVID-19 patients.
Bachler M; Bösch J; Stürzel DP; Hell T; Giebl A; Ströhle M; Klein SJ; Schäfer V; Lehner GF; Joannidis M; Thomé C; Fries D
Br J Anaesth; 2021 Mar; 126(3):590-598. PubMed ID: 33422287
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.
Creel-Bulos C; Auld SC; Caridi-Scheible M; Barker NA; Friend S; Gaddh M; Kempton CL; Maier CL; Nahab F; Sniecinski R
Shock; 2021 Mar; 55(3):316-320. PubMed ID: 32769822
[TBL] [Abstract][Full Text] [Related]
4. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
[No Abstract] [Full Text] [Related]
5. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19).
Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL
Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718
[No Abstract] [Full Text] [Related]
6. Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study.
Henry BM; Cheruiyot I; Benoit JL; Lippi G; Prohászka Z; Favaloro EJ; Benoit SW
Semin Thromb Hemost; 2021 Jun; 47(4):451-455. PubMed ID: 33482678
[No Abstract] [Full Text] [Related]
7. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features of Venous Thromboembolism in Patients With Coronavirus Disease 2019 (COVID-19) in Japan - A Case Series Study.
Yamashita Y; Hara N; Obana M; Ikeda S; Furuichi M; Ishiguro S; Iwai T; Kobayashi T; Mo M; Yamada N
Circ J; 2021 Feb; 85(3):309-313. PubMed ID: 33473096
[TBL] [Abstract][Full Text] [Related]
9. Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in Critically Ill COVID-19 Patients.
Heinz C; Miesbach W; Herrmann E; Sonntagbauer M; Raimann FJ; Zacharowski K; Weber CF; Adam EH
Anesthesiology; 2021 Mar; 134(3):457-467. PubMed ID: 33417674
[TBL] [Abstract][Full Text] [Related]
10. The haemostatic profile in critically ill COVID-19 patients receiving therapeutic anticoagulant therapy: An observational study.
Tsantes AE; Frantzeskaki F; Tsantes AG; Rapti E; Rizos M; Kokoris SI; Paramythiotou E; Katsadiotis G; Karali V; Flevari A; Chrysanthopoulou E; Maratou E; Kyriakou E; Gialeraki A; Bonovas S; Dimopoulos G; Tsangaris I; Armaganidis A
Medicine (Baltimore); 2020 Nov; 99(47):e23365. PubMed ID: 33217881
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.
Meizoso JP; Moore HB; Moore EE
J Am Coll Surg; 2021 Jun; 232(6):995-1003. PubMed ID: 33766727
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and Hypercoagulability: A Review.
Kichloo A; Dettloff K; Aljadah M; Albosta M; Jamal S; Singh J; Wani F; Kumar A; Vallabhaneni S; Khan MZ
Clin Appl Thromb Hemost; 2020; 26():1076029620962853. PubMed ID: 33074732
[TBL] [Abstract][Full Text] [Related]
13. Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients.
Miltiades A; Houck PJ; Monteleone M; Harrison NL; Cabrera-Garcia D; Roh D; Wagener G
J Neurosurg Anesthesiol; 2022 Jan; 34(1):136-140. PubMed ID: 34870637
[TBL] [Abstract][Full Text] [Related]
14. Hemostasis in Coronavirus Disease 2019-Lesson from Viscoelastic Methods: A Systematic Review.
Słomka A; Kowalewski M; Żekanowska E
Thromb Haemost; 2021 Sep; 121(9):1181-1192. PubMed ID: 33401332
[TBL] [Abstract][Full Text] [Related]
15. Complex and prolonged hypercoagulability in coronavirus disease 2019 intensive care unit patients: A thromboelastographic study.
Cordier PY; Pierrou C; Noel A; Paris R; Gaudray E; Martin E; Contargyris C; Bélot-De Saint Léger F; Lyochon A; Astier H; Desmots F; Savini H; Surcouf C
Aust Crit Care; 2021 Mar; 34(2):160-166. PubMed ID: 33509706
[TBL] [Abstract][Full Text] [Related]
16. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
Zuo Y; Warnock M; Harbaugh A; Yalavarthi S; Gockman K; Zuo M; Madison JA; Knight JS; Kanthi Y; Lawrence DA
Sci Rep; 2021 Jan; 11(1):1580. PubMed ID: 33452298
[TBL] [Abstract][Full Text] [Related]
17. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations.
Levy JH; Iba T; Olson LB; Corey KM; Ghadimi K; Connors JM
Int J Lab Hematol; 2021 Jul; 43 Suppl 1(Suppl 1):29-35. PubMed ID: 34288441
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study.
Collett LW; Gluck S; Strickland RM; Reddi BJ
Aust Crit Care; 2021 Mar; 34(2):155-159. PubMed ID: 32773357
[TBL] [Abstract][Full Text] [Related]
19. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019.
Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P
Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463
[No Abstract] [Full Text] [Related]
20. Coronavirus Disease 2019: The Role of the Fibrinolytic System from Transmission to Organ Injury and Sequelae.
Kwaan HC
Semin Thromb Hemost; 2020 Oct; 46(7):841-844. PubMed ID: 32386428
[No Abstract] [Full Text] [Related]
[Next] [New Search]
